Reviews on Long COVID: A scope of the literature. Update October 2024

Claire Louise Khouja; Gary Austin Raine; Melissa Harden; Katy Sutcliffe; Amanda Jayne Sowden

Reviews on Long COVID: A scope of the literature. Update October 2024

Claire Louise Khouja, Gary Austin Raine, Melissa Harden, Katy Sutcliffe, Amanda Jayne Sowden

Centre for Reviews and Dissemination

Research output: Book/Report › Commissioned report

Abstract

• For this update, we identified 38 published reviews and 35 review protocols for Long COVID.
• The number of reviews (n=38) is more than July 2024 (n=33) and April 2024 (n=36), but fewer than January 2024 (n=42) and October 2023 (n=46).
• As in many of the previous reports, the largest category of reviews focused on symptoms or effects (14/38) and the second largest was on treatment or rehabilitation (11/38).
• We identified eight reviews on risk factors with or without prevalence, three on pathobiology or mechanisms, one on prevention, and one on diagnosis or monitoring tools.
• The number of protocols (n=35) is fewer than in every previous report.
• As in previous reports, the largest two categories of protocols focused on the prevalence of symptoms or effects (13/35), and treatment or rehabilitation (10/35).
• We identified six protocols focused on risk factors with or without prevalence; five on pathobiology or mechanisms; and one on diagnosis or monitoring tools.

Original language	English
Place of Publication	London
Publisher	EPPI Centre, UCL Social Research Institute, UCL Institute of Education, University College London
Commissioning body	NIHR Policy Research Programme
Number of pages	30
ISBN (Electronic)	978-1-911605-68-3
Publication status	Published - 15 Nov 2024

Keywords

Long COVID
Systematic reviews
systematic map

Access to Document

Review_update_October24_LO-151124
Authors of the systematic reviews on the EPPI Centre website (http://eppi.ioe.ac.uk/) hold the copyright for the text of their reviews. The EPPI Centre owns the copyright for all material on the website it has developed, including the contents of the databases, manuals, and keywording and data-extraction systems. The centre and authors give permission for users of the site to display and print the contents of the site for their own non-commercial use, providing that the materials are not modified, copyright and other proprietary notices contained in the materials are retained, and the source of the material is cited clearly following the citation details provided. Otherwise, users are not permitted to duplicate, reproduce, re-publish, distribute, or store material from this website without express written permission.
Final published version, 1.43 MBLicence: CC BY-NC

Cite this

@book{3cd83b73e0044493a09caed61d2b782b,

title = "Reviews on Long COVID: A scope of the literature. Update October 2024",

abstract = "• For this update, we identified 38 published reviews and 35 review protocols for Long COVID.• The number of reviews (n=38) is more than July 2024 (n=33) and April 2024 (n=36), but fewer than January 2024 (n=42) and October 2023 (n=46).• As in many of the previous reports, the largest category of reviews focused on symptoms or effects (14/38) and the second largest was on treatment or rehabilitation (11/38).• We identified eight reviews on risk factors with or without prevalence, three on pathobiology or mechanisms, one on prevention, and one on diagnosis or monitoring tools.• The number of protocols (n=35) is fewer than in every previous report.• As in previous reports, the largest two categories of protocols focused on the prevalence of symptoms or effects (13/35), and treatment or rehabilitation (10/35).• We identified six protocols focused on risk factors with or without prevalence; five on pathobiology or mechanisms; and one on diagnosis or monitoring tools. ",

keywords = "Long COVID, Systematic reviews, systematic map",

author = "Khouja, {Claire Louise} and Raine, {Gary Austin} and Melissa Harden and Katy Sutcliffe and Sowden, {Amanda Jayne}",

year = "2024",

month = nov,

day = "15",

language = "English",

publisher = "EPPI Centre, UCL Social Research Institute, UCL Institute of Education, University College London",

}

TY - BOOK

T1 - Reviews on Long COVID

T2 - A scope of the literature. Update October 2024

AU - Khouja, Claire Louise

AU - Raine, Gary Austin

AU - Harden, Melissa

AU - Sutcliffe, Katy

AU - Sowden, Amanda Jayne

PY - 2024/11/15

Y1 - 2024/11/15

N2 - • For this update, we identified 38 published reviews and 35 review protocols for Long COVID.• The number of reviews (n=38) is more than July 2024 (n=33) and April 2024 (n=36), but fewer than January 2024 (n=42) and October 2023 (n=46).• As in many of the previous reports, the largest category of reviews focused on symptoms or effects (14/38) and the second largest was on treatment or rehabilitation (11/38).• We identified eight reviews on risk factors with or without prevalence, three on pathobiology or mechanisms, one on prevention, and one on diagnosis or monitoring tools.• The number of protocols (n=35) is fewer than in every previous report.• As in previous reports, the largest two categories of protocols focused on the prevalence of symptoms or effects (13/35), and treatment or rehabilitation (10/35).• We identified six protocols focused on risk factors with or without prevalence; five on pathobiology or mechanisms; and one on diagnosis or monitoring tools.

AB - • For this update, we identified 38 published reviews and 35 review protocols for Long COVID.• The number of reviews (n=38) is more than July 2024 (n=33) and April 2024 (n=36), but fewer than January 2024 (n=42) and October 2023 (n=46).• As in many of the previous reports, the largest category of reviews focused on symptoms or effects (14/38) and the second largest was on treatment or rehabilitation (11/38).• We identified eight reviews on risk factors with or without prevalence, three on pathobiology or mechanisms, one on prevention, and one on diagnosis or monitoring tools.• The number of protocols (n=35) is fewer than in every previous report.• As in previous reports, the largest two categories of protocols focused on the prevalence of symptoms or effects (13/35), and treatment or rehabilitation (10/35).• We identified six protocols focused on risk factors with or without prevalence; five on pathobiology or mechanisms; and one on diagnosis or monitoring tools.

KW - Long COVID

KW - Systematic reviews

KW - systematic map

M3 - Commissioned report

BT - Reviews on Long COVID

PB - EPPI Centre, UCL Social Research Institute, UCL Institute of Education, University College London

CY - London

ER -